Tag: Biotech
Biotech IPOs surge 68.4% YoY to $8.52 billion in 2024 amid...
According to GlobalData’s Pharmaceutical Intelligence Center Deals Database, completed IPOs that raised more than $100 million almost doubled, from $4.39 billion across 15 IPOs in 2023 to $7.88 billion across 24 IPOs in 2024
T&D Diagnostics starts manufacturing its Starkwert FIA Range in India
The company has entered into a strategic partnership with Genenest – A Noida-based Biotech company to manufacture its FIA range in India
BioVoice eMagazine April 2025 | Issue 4 | Volume 6
The Cover Story analyzes the blockbuster opportunity for India's biopharma industry. Read interviews of Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited; Sachin Joshi, MD & Founder, PharmNXT Biotech; Mandeep Singh Kumar, MD and Vice President, Medtronic India; and Harshvardhan Bhagchandka, President, IPL Biologicals
Sai Life Sciences sets up peptide research center in India
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Avantor recognized with two prestigious awards at Asia-Pacific Biopharma Excellence Awards...
Awards highlight Avantor's commitment to the biopharma industry
Centre to extend full support for Andhra Pradesh’s biotech push: Dr...
Andhra Pradesh Health Minister Satya Kumar calls on Union Minister Dr Jitendra Singh, seeks greater collaboration with Centre to boost biotechnology
Union govt to collaborate with States to establish regional BIRAC centers...
Mapping of States based on their biotech potential and collaborating to set up Bio E3 Cells
Leucine Rich Bio partners with Trinature Wellness to expand BugSpeaks in...
This partnership builds on Leucine Rich Bio’s robust global footprint, with successful collaborations including Cognoa International Inc. in the Philippines, Medsol Diagnostics in the UAE, and distributors in Thailand and Brazil
BIRAC Turns 13: Dr Jitendra Singh releases India Bioeconomy Report 2025
India's bio-economy has witnessed a remarkable 16-fold rise in 10 years of the past one decade, from $ 10 Billion in 2014 to an impressive $165.7 Billion in 2024, claimed the Minister
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services






























































